Anti-hypertensive therapy in the elderly and its effects on cerebral function.
Seventeen patients ranging in age from 67 to 86 years were entered into a double-blind, crossover study of Moducren and placebo. Psychometric testing using the Clifton Assessment Procedure for the Elderly was performed at the start of the study and at the end of each 4-week test period. The total length of the study was 18 weeks. Apart from effectively reducing blood pressure in elderly hypertensives without causing a high incidence of side effects, plasma potassium, blood urea and cerebral function were all unaffected by Moducren.